Table 3.
Comparison of local complications in the four groups in patients with AP
| Variables | non-HTG + non-AO | HTG + non-AO | non-HTG + AO | HTG + AO | P |
|---|---|---|---|---|---|
| (n = 417) | (n = 286) | (n = 188) | (n = 328) | ||
| Local Complications (n, %) | 259 (62.11) | 218 (76.22) a | 139 (73.94) | 269 (90.24) a c | < 0.001 |
| APFC (n, %) | 238 (57.07) | 211 (73.78) a | 131 (69.68) | 262 (79.88) a c | < 0.001 |
| ANC (n, %) | 10 (2.40) | 11 (3.85) | 7 (3.72) | 27 (8.23) a | 0.001 |
| PPC (n, %) | 7 (1.68) | 6 (2.10) | 4 (2.13) | 14 (4.27) | 0.135 |
| WON (n, %) | 0 (0.00) | 1 (0.35) | 0 (0.00) | 3 (0.91) | 0.098* |
| IPN (n, %) | 0 (0.00) | 1 (0.35) | 0 (0.00) | 0 (0.00) | 0.407* |
| MCTSI (mean ± SD) | 4.09 ± 2.25 | 4.94 ± 1.75 a | 4.29 ± 2.07 b | 4.74 ± 1.86 a c | < 0.001 |
APFC: acute peripancreatic fluid collection; ANC: acute necrotic collection; PPC: pancreatic pseudocyst; WON: walled-off necrosis; IPN: infectious pancreatic necrosis; OF: organ failure; POF: persistent organ failure; TOF: transient organ failure; SIRS: systemic inflammatory response syndrome; MCTSI: modification of CT severity index; a P < 0.05, compared with the non-HTG + non-AO group; b P < 0.05, compared with the HTG + non-AO group; c P < 0.05, compared with the non-HTG + AO group; * Fisher’s exact test